Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 77, Issue 4, Pages 1533-1543Publisher
IOS PRESS
DOI: 10.3233/JAD-200678
Keywords
Corneal confocal microscopy; corneal nerve fibers; dementia; medial temporal lobe atrophy; mild cognitive impairment; neuropathology
Categories
Funding
- Qatar National Research Fund [BMRP-5726113101, NPRP12S0213-190080]
- NPRP from the Qatar National Research Fund (a member of Qatar Foundation) [NPRP12S-0213-190080]
Ask authors/readers for more resources
Background: Visual rating of medial temporal lobe atrophy (MTA) is an accepted structural neuroimaging marker of Alzheimer's disease. Corneal confocal microscopy (CCM) is a non-invasive ophthalmic technique that detects neuronal loss in peripheral and central neurodegenerative disorders. Objective: To determine the diagnostic accuracy of CCM for mild cognitive impairment (MCI) and dementia compared to medial temporal lobe atrophy (MTA) rating on MRI. Methods: Subjects aged 60-85 with no cognitive impairment (NCI), MCI, and dementia based on the ICD-10 criteria were recruited. Subjects underwent cognitive screening, CCM, and MTA rating on MRI. Results: 182 subjects with NCI (n = 36), MCI (n = 80), and dementia (n = 66), including AD (n = 19, 28.8%), VaD (n = 13, 19.7%), and mixed AD (n = 34, 51.5%) were studied. CCM showed a progressive reduction in corneal nerve fiber density (CNFD, fibers/mm(2)) (32.0 +/- 7.5 versus 24.5 +/- 9.6 and 20.8 +/- 9.3, p < 0.0001), branch density (CNBD, branches/mm(2)) (90.9 +/- 46.5 versus 59.3 +/- 35.7 and 53.9 +/- 38.7, p < 0.0001), and fiber length (CNFL, mm/mm(2)) (22.9 +/- 6.1 versus 17.2 +/- 6.5 and 15.8 +/- 7.4, p < 0.0001) in subjects with MCI and dementia compared to NCI. The area under the ROC curve (95% CI) for the diagnostic accuracy of CNFD, CNBD, CNFL compared to MTA-right and MTA-left for MCI was 78% (67-90%), 82% (72-92%), 86% (77-95%) versus 53% (36-69%) and 40% (25-55%), respectively, and for dementia it was 85% (76-94%), 84% (75-93%), 85% (76-94%) versus 86% (76-96%) and 82% (72-92%), respectively. Conclusion: The diagnostic accuracy of CCM, a non-invasive ophthalmic biomarker of neurodegeneration, was high and comparable with MTA rating for dementia but was superior to MTA rating for MCI.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available